235 related articles for article (PubMed ID: 32020063)
1. Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis.
Acha-Sagredo A; Uko B; Pantazi P; Bediaga NG; Moschandrea C; Rainbow L; Marcus MW; Davies MPA; Field JK; Liloglou T
Br J Cancer; 2020 Mar; 122(7):1050-1058. PubMed ID: 32020063
[TBL] [Abstract][Full Text] [Related]
2. [Progress in Role of FEZF1-AS1 in Non-small Cell Lung Cancer].
Chen J; Yin R; Liu X
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):294-298. PubMed ID: 32228826
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.
Lv J; Qiu M; Xia W; Liu C; Xu Y; Wang J; Leng X; Huang S; Zhu R; Zhao M; Ji F; Xu L; Xu K; Yin R
J Exp Clin Cancer Res; 2016 May; 35():75. PubMed ID: 27154193
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
5. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
[TBL] [Abstract][Full Text] [Related]
7. Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells.
Miao L; Huang Z; Zengli Z; Li H; Chen Q; Yao C; Cai H; Xiao Y; Xia H; Wang Y
Oncotarget; 2016 Oct; 7(42):68339-68349. PubMed ID: 27577075
[TBL] [Abstract][Full Text] [Related]
8. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.
Zhang M; Wu J; Zhong W; Zhao Z; Liu Z
Arch Biochem Biophys; 2018 Dec; 660():53-63. PubMed ID: 30227111
[TBL] [Abstract][Full Text] [Related]
10. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.
Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W
Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA actin filament-associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine-specific demethylase 1 and repressing HMG box-containing protein 1 in non-small-cell lung cancer.
Yu S; Yang D; Ye Y; Liu P; Chen Z; Lei T; Pu J; Liu L; Wang Z
Cancer Sci; 2019 Jul; 110(7):2211-2225. PubMed ID: 31069893
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression and poor prognosis in patients with non-small cell lung cancer.
Zhao QS; Li L; Zhang L; Meng XW; Li LL; Ge XF; Li ZP
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3031-4. PubMed ID: 27460731
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA DSCAM-AS1 functions as an oncogene in non-small cell lung cancer by targeting BCL11A.
Liao J; Xie N
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1087-1092. PubMed ID: 30779076
[TBL] [Abstract][Full Text] [Related]
14. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer.
He J; Wu K; Guo C; Zhou JK; Pu W; Deng Y; Zuo Y; Zhao Y; Liu L; Wei YQ; Peng Y
Cell Mol Life Sci; 2018 Dec; 75(24):4667-4681. PubMed ID: 30293090
[TBL] [Abstract][Full Text] [Related]
18. A MYC target long non-coding RNA GATA2-AS1 regulates non-small cell lung cancer growth.
Zhang L; Gao L; Shao M; Sun GY
Neoplasma; 2019 Nov; 66(6):954-962. PubMed ID: 31607132
[TBL] [Abstract][Full Text] [Related]
19. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
20. Identification of LHFPL3-AS2 as a prognostic biomarker in lung adenocarcinoma.
Zhou X; Liu G; Lin M; Li L; Cao D
Indian J Pathol Microbiol; 2022; 65(2):288-295. PubMed ID: 35435361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
